CT SB00545 | 2017 | General Assembly
Status
Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on January 23 2017 - 25% progression, died in committee
Action: 2017-01-26 - Reserved for Subject Matter Public Hearing
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 23 2017 - 25% progression, died in committee
Action: 2017-01-26 - Reserved for Subject Matter Public Hearing
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [HTML]
Summary
To require a study and report on the processes that insurance companies, hospital service corporations, medical service corporations, health care centers and other entities that use step therapy for prescription drugs employ in assessing requests made by treating health care providers to override the use of step therapy drug regimens for insureds diagnosed with metastatic cancer and the response time to such requests.
Title
An Act Concerning A Study Of Requests By Health Care Providers To Override Step Therapy Drug Regimens For Certain Cancer Patients.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2017-01-26 | Senate | Reserved for Subject Matter Public Hearing |
| 2017-01-23 | Senate | Referred to Joint Committee on Insurance and Real Estate |
Connecticut State Sources
| Type | Source |
|---|---|
| Summary | https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00545&which_year=2017 |
| Text | http://www.cga.ct.gov/2017/TOB/s/2017SB-00545-R00-SB.htm |
